Insider · CIK 0001657494

Aurentz Vincent

Reports to the SEC for 4 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001657494

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+155K sh	—	—	155,000
2026-02-21	IKTInhibikase Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−255K sh	—	—	510,596
2025-06-30	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+108K sh	—	—	108,176
2025-02-21	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+134K sh	—	—	134,427
2025-02-21	IKTInhibikase Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+134K sh	—	—	134,427
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.4K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.4K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,214 sh	—	—	0
2024-05-23	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-05-25	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-05-24	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,367
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−75K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Executive VP and CBO	JOther	−27.8K sh	—	—	28,122
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Executive VP and CBO	JOther	−6,660 sh	—	—	21,462
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Executive VP and CBO	JOther	−21.5K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−45K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−77K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−95K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−70K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−38.9K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitD Disposition to Issuer	Executive VP and CBO	DDisposition to Issuer	−15.2K sh	—	—	0
2022-01-03	ARENA PHARMACEUTICALS INCA Award	Executive VP and CBO	AAward	+21.5K sh	—	—	55,122
2021-09-14	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,367
2021-09-14	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,214 sh	—	—	7,214
2021-03-01	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitA Award	Executive VP and CBO	AAward	+15.2K sh	—	—	15,200
2021-03-01	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CBO	AAward	+38.9K sh	—	—	38,850
2021-03-01	ARENA PHARMACEUTICALS INCA Award	Executive VP and CBO	AAward	+6,660 sh	—	—	33,660
2021-02-16	ARENA PHARMACEUTICALS INCS Sale	Executive VP and CBO	SSale	−2,524 sh	$85.00	−$215K	27,000
2021-02-16	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+2,500 sh	$14.60	+$36.5K	29,500
2021-02-16	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−24 sh	—	—	94,976
2021-02-16	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−2,500 sh	—	—	77,000
2021-02-16	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+24 sh	$35.60	+$854.4	29,524
2021-01-07	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−18K sh	—	—	0
2021-01-07	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+18K sh	—	—	27,000
2020-11-25	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−9,000 sh	—	—	18,000
2020-11-25	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+9,000 sh	—	—	9,000
2020-06-02	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+10K sh	$14.60	+$146K	20,000
2020-06-02	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+5,000 sh	$35.60	+$178K	25,000
2020-06-02	ARENA PHARMACEUTICALS INCS Sale	Executive VP and CBO	SSale	−25K sh	$65.00	−$1.63M	0
2020-06-02	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−10K sh	—	—	45,000
2020-06-02	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−10K sh	—	—	79,500
2020-06-02	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−5,000 sh	—	—	95,000
2020-06-02	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+10K sh	$17.10	+$171K	10,000
2020-03-01	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CBO	AAward	+70K sh	—	—	70,000
2020-02-05	ARENA PHARMACEUTICALS INCS Sale	Executive VP and CBO	SSale	−9,000 sh	$50.00	−$450K	0
2019-10-14	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	+9,000 sh	—	—	9,000
2019-10-14	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	Executive VP and CBO	MExercise/Conversion	−9,000 sh	—	—	27,000
2019-09-09	ARENA PHARMACEUTICALS INCS Sale	Executive VP and CBO	SSale	−20.3K sh	$51.23	−$1.04M	0

Recent filings

Accepted (ET)
Jun 304
Aurentz Vincent0001193125-26-290472
SEC(opens sec.gov)
Feb 244
Aurentz Vincent0001193125-26-068079
SEC(opens sec.gov)
Jul 24
Aurentz Vincent0000950170-25-093436
SEC(opens sec.gov)
Jul 24/A
Aurentz Vincent0000950170-25-093440
SEC(opens sec.gov)
Feb 254
Aurentz Vincent0000950170-25-026650
SEC(opens sec.gov)
Dec 24
Aurentz Vincent0001415889-24-028024
SEC(opens sec.gov)
May 244
Aurentz Vincent0000950170-24-064588
SEC(opens sec.gov)
May 264
Aurentz Vincent0001209191-23-032501
SEC(opens sec.gov)
May 314
Aurentz Vincent0001209191-22-032731
SEC(opens sec.gov)
Mar 114
Aurentz Vincent0001628280-22-005885
SEC(opens sec.gov)

Companies

Address

1000 N. WEST STREET, SUITE 1200

WILMINGTON, DE, 19801